Full-Time

Operations IT Business Partner

Posted on 4/4/2025

AstraZeneca

AstraZeneca

10,001+ employees

Develops and commercializes prescription medicines

Compensation Overview

$119.9k - $179.8k/yr

+ Short-term incentive bonus + Equity-based long-term incentive program

Senior, Expert

San Carlos, CA, USA

Minimum of three days per week in-office required.

Category
Generalist Operations
Operations & Logistics
Requirements
  • Bachelor’s Degree in a technical field
  • 7+ years of experience in an operations/IT environment
  • Strong verbal and written communication skills
  • Good influencing, networking, and team working skills
  • High level awareness of developments in the Information Technology marketplace
  • Skills in planning, change management, and problem-solving
  • Ability to negotiate expectations with complex groups
  • Ability to interpret and communicate technical information into business language and vice versa
  • Ability to articulate the benefits of innovative solutions aligned to the business area and organization
  • Identification and implementation of innovative technology solutions
  • Experience of contributing to high-value business cases & mobilizing high-value investments
  • Experience with third-party suppliers and have strong network and consulting skills
  • Relationship building skills with the ability to influence others to achieve objectives
  • Proven ability to relate and respond to business needs in an IT environment
Responsibilities
  • Build strong relationships with stakeholder groups, developing a deep understanding of the short-term and long-term business direction.
  • Assess and prioritize requirements in line with IT strategy.
  • Develop and maintain the customer account plan, including accurate customer forecasting, demand planning, and effective delivery of the plan.
  • Develop business impact assessment, identifying risks and issues that may affect current and future business units and roles, and create a business readiness plan.
  • Develop and maintain performance metrics and proactively identify areas for improvement.
  • Present and gain commitment to IT initiatives, using specialist knowledge to gain commitment to established or new IT services.
  • Work collaboratively with IT Strategy, Capabilities, Architecture, Portfolio Management, and Project/Program Management functions to agree on the future shape of proposed solutions and manage business expectations of outcomes.
  • Work with business representatives and IT to conduct high-level investigations on requirements specifications and feasibility studies to advise on the practicability of alternatives marrying up technical limitations with operational realities.
  • Collaborate with other customer area Business Partners to create alignment and identify cross-business innovative opportunities.
  • Initiate projects with Portfolio Managers and solution delivery leads, clearly define scope, and monitor the delivery of project value compared to the promised benefits.
  • Ensure the IT services plans are established for the customer group and are operating effectively.
Desired Qualifications
  • Work experience in a pharmaceutical or regulated industry
  • Ability to work well in and across diverse global teams
  • Ability to partner and work in a matrix organization
  • Agile development methodologies

AstraZeneca focuses on discovering, developing, and selling prescription medicines. The company specializes in three main areas: Oncology, which deals with cancer treatment; Cardiovascular, Renal & Metabolism, which addresses heart, kidney, and metabolic diseases; and Respiratory & Immunology, which targets lung and immune system diseases. Their products are developed through extensive research and development, followed by clinical trials and regulatory approvals before reaching the market. AstraZeneca differentiates itself from competitors by investing heavily in scientific research and fostering collaborations through initiatives like their Open Innovation program, which shares resources with the scientific community to speed up drug discovery. Their goal is to advance healthcare by creating effective treatments for serious diseases and expanding their product offerings through strategic partnerships.

Company Size

10,001+

Company Stage

IPO

Headquarters

Cambridge, United Kingdom

Founded

1913

Simplify Jobs

Simplify's Take

What believers are saying

  • AI-driven drug discovery enhances AstraZeneca's R&D efficiency and innovation.
  • Real-world evidence supports AstraZeneca's drug efficacy and safety demonstrations.
  • Personalized medicine aligns with AstraZeneca's focus on precision therapies.

What critics are saying

  • Class-action lawsuit over Soliris could lead to legal costs and reputational damage.
  • AI tool for breast cancer screening may face challenges in minority representation.
  • Foreign investment regulations in France may impact AstraZeneca's Dunkirk expansion.

What makes AstraZeneca unique

  • AstraZeneca excels in oncology, cardiovascular, and respiratory therapeutic areas.
  • The A.Catalyst Network fosters global collaboration and innovation in healthcare.
  • Open Innovation program accelerates drug discovery by sharing compounds and technologies.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Paid Vacation

Paid Holidays

Flexible Work Hours

Company News

Cision
Apr 22nd, 2025
Enhertu Combination Improved Pfs In 1L Her2+ Mbc

Enhertu combination improved PFS in 1L HER2+ mBC

Life Sciences IP Review
Apr 17th, 2025
AstraZeneca unit faces class-action suit over alleged Soliris monopoly

AstraZeneca unit faces class-action suit over alleged soliris monopoly.

Our Health Needs
Apr 11th, 2025
Study: Racial, ethnic minorities are underrepresented in AI mammogram interpretation

In 2024, AI biotech company Owkin partnered with pharma giant AstraZeneca to develop an AI-powered tool designed to pre-screen for gBRCA mutations (gBRCAm) in breast cancer directly from digitized pathology slides.

Medical Update Online
Apr 11th, 2025
AstraZeneca showcases progress in immunisation and real-world evidence addressing global infectious disease burden at ESCMID Global 2025

AstraZeneca showcases progress in immunisation and real-world evidence addressing global infectious disease burden at ESCMID Global 2025.

Cision
Apr 11th, 2025
Result Of Agm

11 April 2025Results of Annual General Meeting held on 11 April 2025AstraZeneca PLC announced the results of the voting at its Annual General Meeting (AGM) today. As proposed in the Notice of AGM, all Resolutions were decided by poll vote. Resolutions 9 - 12 were passed as special resolutions; all other resolutions were passed as ordinary resolutions.Resolution. Votes for. % of votes cast

INACTIVE